chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Administration of vaccine was painful.  Felt like the person administering it really pushed hard into my arm. Immediate soreness did not dissipate over coming days.  In fact my arm continued to hurt more over time.  Within two weeks I noticed diminished range of motion with my arm.  The pain I would feel when raising my arm upwards started at my shoulder and would reverberate down my arm.  On Oct. 17th, 2013 I went to see my general practitioner as the pain was increasing and affecting my ability to perform regular work and home related tasks.  The doctor told me to take 2 Aleve 2 times daily, put ice on my shoulder, and try to increase my range of motion by moving my arm in the areas it does not want to go. After one week with very little change my general practioner sent my to orthopedics for physical therapy.  I started physical therapy on 10/28/2013 and have gone twice a week for the past two weeks. I have begun to regain a certain amount of movement and range of motion in some directions.  There is still immense pain in inability to move my arm in other directions (mainly backwards).  Daily I am working on a series of exercises and am going to continue seeing the physical therapist.  While I am able to perform many of my regular daily tasks, there I some things I am just not able to do without feeling a great deal of pain.  No matter what I do, I do feel a stabbing pain starting in my shoulder area periodically in just doing regular movements.  I had none of this prior to the administration of the flu vaccine on 9/26/2013. I did not do anything unusual during that time that would have caused any of this.
Patient received adult Pfizer vaccine, though they are 11 years old. No adverse reaction reported.
One week after receiving vaccine started to begin having chills, extreme muscle and joint aches, flushing of face
Vocal fold paralysis.  Scheduled for a laryngoscopy, direct, with injection into vocal cord.
Stroke, two, small, frontal lobe  1.3 cm and 1.5 cm on MRI. Stroke occurred 2 weeks after vaccination .
Fever, chills, body ache, headache, lightheaded.  All symptoms resolved by 1/31/21 except headache and lightheadedness. Took 1 maxalt for headache on 1/30/21.   Took 600mg ibuprofen on 2/1/21. Took excedrin migraine on 2/2/21 and 2/3/21.
feeling under the weather; has this hoarseness in her voice whenever she speaks; coughing; not feeling well during the morning; This is a spontaneous report from a contactable consumer or other non hcp (patient) from Pfizer sponsored program.  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: not reported), dose 2 via an unspecified route of administration on 22Feb2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: not reported), via an unspecified route of administration, administered on 01Feb2021 as dose 1, single for COVID-19 immunisation. received her 1st vaccine on 01Feb2021 and her 2nd vaccine on 22Feb2021.  On 25Feb2021, the patient experienced feeling under the weather, has this hoarseness in her voice whenever she speaks, coughing. On an unspecified date in 2021,  the patient was not feeling well during the morning. However, upon talking reported that she experienced feeling under the weather after 3 days of receiving the 2nd vaccine.she was not feeling well during the morning. However, that did not last very long as she felt a little better later that afternoon. Consequently, had this hoarseness in her voice whenever she speaks accompanied by coughing. Referred to the local health authority/vaccination facility for her lost card. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
took the shot on Monday  woke up Tuesday morning with pink eye on my left eye  and body broke out in a rash by Tuesday at 4 pm   today is Wednesday and I have the rash all over my body
Patient is a 66 y.o. male patient of, DO with history of atrial fibrillation, type 2 diabetes, essential pretension, hyperlipidemia presented to Hospital with palpitations and found to be in A-fib with RVR.   A-fib with RVR Fluid overload Essential hypertension Heart rate in the 120s on admission, improved and in 90's. Status post boluses of Lopressor EKG with A-fib with RVR Troponin 25>26, neg delta  Elevated proBNP at 1853. TSH within normal limit X-ray with signs suggesting pulmonary edema Last echo 2018 with a EF 50 to 55% with global hypokinesis Nuclear medicine 2018 With normal myocardial perfusion Likely triggered by COVID pneumonia Resumed home Coreg.  Resume home Coumadin an Resume home Coumadin and ramipril Lasix 20 mg IV BID. Echo with EF 59% Strict I's and O's with daily weight monitoring, - 10 L negative balance Increase ramipril to 10 mg secondary to uncontrolled blood pressure and Added amlodipine 5 mg on 3/29 Increase amlodipine to 10 mg on 4/1 secondary to uncontrolled blood pressure Pharmacy managing Coumadin dosing, latest INR 2.8 Continue 5 mg Coumadin on discharge until INR clinic follow-up, discussed with pharmacy Blood pressure stable and improved on 4/2/2023 Recommend PCP follow-up for close monitoring of blood pressure     Acute hypoxic respiratory failure...resolved O2 sat in the mid 80s Currently on nasal cannula with sats in 90's Likely in the setting of COVID contributed by A-fib with RVR Plan as below for COVID Weaned to RA 03/8 Covid-19 Virus Infection Possible viral PNA Date of onset of symptoms: Couple of days Symptoms present on admission: Shortness of breath, intermittent coughs Date of covid positive test: 3/24/2023 Vaccination status: vaccinated Imaging: Chest x-ray with moderate pulmonary edema and stable cardiomegaly. Oxygen requirements on admission: Nasal cannula2 L Current oxygen requirements: RA Medical therapy: steroids/remdesivir Consultants following: e-ID End isolation date on 4/3   Type 2 diabetes, non-insulin-dependent Last A1c 9.8 on 1/9/2023 Blood sugar 314 this admission On lantus 24 units nightly and glipizide and Ozempic  Ordered lantus 34units with SSI/POCTS/Hypoglycemia protocol as needed  Titrated lantus to 38 units with SSI adjused to normal from sensitive given elevated BS and steroid use, uptitrated to 42 units, changed SSI to resistant Uptitrated lantus to 50 units 03/28 Blood glucose remain elevated, appreciate endocrinology assistance Recommend to continue Lantus 50 units and start carb count prandial coverage Uptitrated lantus to 70 units by endocrine team along with carb count gradual dose 03/31 and 18 units on 4/1 Monitor BS, improving, endo following Discussed with Endo, will discharge on 70 units of Lantus to be taken on 4/3 and from there onwards 40 units of Lantus after Decadron doses finished   Elevated transaminases On remdesivir, last dose on 3/29 Will discontinue as patient stable on room air Avoid hepatotoxic agents LFTs stable and improved 03/30 Monitor CMP
Received Covid-19 booster on 02-18-2022 at 12:25pm. I felt many chills, sweats and body aches throughout Saturday 02-19-2022. At around 5am on Sunday 02-20-2022 I was awakened by a pinching sensation in left axilla (vaccination had been to left deltoid)-found an area of swelling approx. 3 inch oval painful lymph node. Monday morning 02/21/2022 the lymph nodes to left clavicle and lateral neck swollen.
I received my 4th vaccine on the 11/21/2022.  After 1 week of my  vaccine on 11/27/2022  at around 8:00AM.  In the morning. I had  fever, body aches,  fatigue,  chest congestions, chills and runny nose. I went to the Urgent Health  Clinic on 12/04/2022 when the same symptoms came back. They prescribed  medication for 10 days.
I received step one of the Pfizer COVID-19 vaccine on 12/30 at 12:05pm and my symptoms started on 12/31 at 03:00am. I began experiencing numbness and tingling in my left arm and hand that progressed to the left side of my tongue and face (left cheek, left chin area and left upper side of lip). I also noted a similar feeling in my mid-back on both sides. My facial symptoms improved around 06:00, but I can still feel numbness and tingling in my left arm and hand to the same extent at the time of documenting this report (08:10). The numbness and tingling in my tongue and face is still technically there, but less pronounced. I no longer feel it in my back.
The patient presents with dehydration.  The onset was just prior to arrival and abrupt.  The course/duration of symptoms is constant.  The degree at onset was minimal.  The degree at present is moderate.  Risk factors consist of coronary artery disease, hypertension and cardiomyopathy s/p heart transplant.  Prior episodes: occasional.  Therapy today: oral fluids.  Associated symptoms: myalgia and weakness.  Additional history: Received his 3rd COVID booster earlier today.  Was working in the concession stand at the game tonight and then had acute onset of low back pain and spasm and feeling a little weak.  Worried would get worse and possibly due to a reaction from the vaccine and came the ER for evaluation.  With his 2nd COVID shot he reportedly had a brief syncopal spell.  Denies chest pain, palpitations, SOB, or cough now.  No nausea,vomitting, diarrhea, or change in stools or urination.  Has been compliant with this meds.
received vaccine from expired vial/183 people were vaccinated with these expired vials.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received vaccine from expired vial/183 people were vaccinated with these expired vials.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (received vaccine from expired vial/183 people were vaccinated with these expired vials.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received vaccine from expired vial/183 people were vaccinated with these expired vials.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medication was provided. No treatment  was provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Dec-2021: Non Significant follow-up appended
Diarrhea that lasted approximately 2 weeks. I ended up self medicating with a probiotic and it cleared right up
Itchy and swelling about the size of golf ball.  Looked up online they called it covid arm.
44 days post covid positive; 44 days post covid positive; Arm soreness; Body aches; Fatigue; Random nerve pain on sides; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot and expiry were not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that Covid vaccine given to the patient, 44 days post covid positive. The reported side effects were arm soreness, body aches, fatigue, random nerve pain on sides. Events took place after use of product. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
immediately post vaccination pt arm felt tingly she said. 15 mins later it radiated to her lower arm. pt waited additional time and pt wanted to leave. bp is 113/80 pulse rate 91
12/13 6:00pm  received my Maderna Booster at Pharmacy in left arm 12/13 9:00pm left arm started hurting badly and felt pain all night while trying to sleep 12/14  All day had very bad flu symptoms of chills, head ache and body ache; by late evening around 9pm I was finally feeling better;  Even my arm wasn't as sore but I had pain travel to my left clavicle and felt a "large blueberry" size nodule on my clavicle about 1 inch from the end of my clavicle nearest my shoulder.  The pain on my clavicle was tender to touch. 12/17  The nodule remains on my clavicle and is tender to touch.  Arm pain gone.
PATIENT is 17 . Moderna Vaccine  FOR Covid-19 is indicated FOR  18 + Older. Family WANT PATIENT to get 2nd Dose 1 PATIENT is 17 YEARS OLD. 2 Moderna Covid-19 Vaccine        is indicated FOR age 18 + OVER. 3 PATIENTS fatheR refused to allow us to contact the Primary DoctoR 4 PATIENTS Father WANTS Patient to ReciEvE the Second dose.
Information has been received from a nurse concerning a 60 year old male who on approximately 30-MAY-2008 was vaccinated with a dose of VARIVAX (Merck) instead of ZOSTAVAX (Merck). The patient had no reaction. The patient's outcome was unknown. No further information is available.
I had side effects that lasted for 3 weeks which were aches, pain, fatigue, and tiredness. I was rushed to Hospital and diagnosed with Atrial fibrillation.  After I was released from the hospital, I was experiencing weight loss and energy. I saw my doctor and tests were ran and everything came back normal.
1340-EE c/o nauseated( with heaves but no emesis), dizziness, with a severe HA. BP 193/83 HR 62 O2  88-96%RA; 1345-EE to ED room 14 for further evaluation.
Febrile seizure 27OCT PM taken to ER dx made of febrile seizure secondary to BOM;
Immediate back pain, that lasted approximately 5 months. Pain eventually spread to my right leg and foot. My monthly cycle changed. It became extremely heavy and lasts for up to 10 days. During my cycle I experience vertigo, nausea and extreme migraines. My blood pressure is erratic and constantly fluctuating.  I have ear pain in both ears and ringing  in both ears, but the left ear is far worse.
Paralisis facial/Facial paralysis; This is a spontaneous report from a contactable consumer (patient). A 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; lot number: EP6955), via an unspecified route of administration, administered in the left arm on 08Apr2021 (at the age of 60-years-old) as dose 2, single for COVID-19 immunization. Medical history included prostate cancer. The patient has no known allergies. Prior to vaccination, the patient had no history of COVID-19. Concomitant medications included ascorbic acid (VITAMIN C), colecalciferol (VITAMIN D 3), and cyanocobalamin (VITAMIN B12). The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EP7534) via an unspecified route of administration, administered in the left arm on 17Mar2021 (at the age of 60-years-old) as dose 1, single for COVID-19 immunization. Since the vaccination, the patient has not been tested for COVID-19. On 15Apr2021 13:00, the patient experienced paralisis facial/facial paralysis which resulted in emergency room visit and physician's office visit. Therapeutic measures were taken as result of the event which included physical therapy and prednisone. The outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Can hardly move arm, high fever, bad aches everywhere, pounding headache, no appetite.
02/01/2021 Vaccination 2nd. dose 02/02/2021 Generalized pain, intense fever at night with chills 02/03/2021 Severe pain in the joints (shoulders, knees, ankles), fever at night 02/04/2021 Severe pain in the joints (shoulders, knees, ankles), fever at night 02/05/2021 Severe pain in the joints (shoulders, knees, ankles) 02/06/2021 Severe pain in the joints (shoulders, knees, ankles) 02/07/2021 Minimal pain in joints 02/08/2021 Elimination of signs and symptoms, coordination of maintenance visit and follow-up next week
11/11/16-Patient reports arm soreness from elbow to shoulder and neck. Reports treatment at home with ibuprofen. Reported in left arm only.
Hospitalized 2/19/22-3/5/22 Hypoxia, altered mental status, PE, respiratory failure, PNA, elevated troponin, pleural effusions, fever with chills, dyspnea, "obtunded,"
Redness, swelling, itching, temp, headache; more severe than led to believe by brochure. Redness covered from above shoulder to 3/4s of way to elbow and full side-to-side involvement.
Slept p/shots; appr. 3.5-4 hrs later PT began crying & could not be comforted; seemed lethargic & pale; 27AUG91 remains pale, but is responsive & not crying; 6PM 26AUG to 5AM 27AUG crying intermittently, sometimes screaming;
A non-serious spontaneous report of administration of expired dose was received from a health professional concerning a 16-year-old male. Neither relevant medical history nor concomitant medications have been reported for this patient. On 21-Nov-2011, two patients received the expired FLUMIST. The product expired on 20-Nov-2011. On 21-Nov-2011, the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
Pain in left arm. Decreased functionality. Left arm shakes. Patient is left handed and it has affected day to day life. Difficulty sleeping as well. She has consulted her physician.
101 Degree temperature, headache, fatigue starting next day and lasting for 48 hours After 3 days red spot upper arm (NOT at injection site) which spread over next 3 days from upper arm to elbow and smaller areas on inner arm from elbow to wrist.  Skin was warm to touch and slightly swollen.  These symptoms begin to subside on the 7th day and redness was gone after 9 days.
The patient at the age of 1 year in 1997 was vaccinated with one dose of varicella virus vaccine live. On 03/16/2001 the patient developed herpes zoster, "shingles" on her right arm. The patient was seen by a dermatologist who sent an isolated culture. The result of the culture was unknown, since they were not able to isolate or grow the culture or determine whether it was wild type or vaccine. Additional information has been requested.
Top lip swelled up; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Top lip swelled up) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced LIP SWELLING (Top lip swelled up). The patient was treated with IBUPROFEN for Lip swelling, at an unspecified dose and frequency. At the time of the report, LIP SWELLING (Top lip swelled up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Initial information received on 22-Aug-2018 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 48 years old male patient who experienced pulling in his right shoulder, numbness and tingling down his right arm whenever he moved neck up/down to the left side, while he received vaccine FLUZONE QUADRIVALENT. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 05-Jun-2018 at 04:30 PM, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UI856AB via intramuscular route in the right deltoid. On 12-Aug-2018 at 12:00 PM, the patient developed a non-serious pulling in his right shoulder, numbness, tingling down his right arm whenever he moved neck up/down to the left side, one month 27 days 19 hours 30 minutes following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Relevant tests were not reported. Final diagnosis was pulling in his right shoulder, numbness and tingling down his right arm whenever he moved neck up/down to the left side. It was not reported if the patient received a corrective treatment. On an unknown date, the patient was recovered from the events. List of documents held by sender: none.
w/in 12hr noted itchy, red rash onset on chest then spread to back then to arms over next few days;pt achy w/congestion, myalgias, cough;devel local induration @ shot site w/in 24-36hr as well;T101-102 oral w/h/a;rash seen diffuse maculopap
This spontaneous report as received from a physician via a company representative refers to a male patient of unknown age with diabetes. On an unknown date the patient was vaccinated with a dose of PNEUMOVAX 23, (lot#, expiration date, dose and route not reported), "Because of Diabetic Status". The patient developed pain, swelling, and erythema at the injection site after receiving PNEUMOVAX 23. The patient was seen in an unspecified emergency room on an unspecified date and received an unspecified antibiotic. On an unknown date, the patient was recovered from the adverse events. Additional information has been requested.
After vaccine admin. pt went out to eat breakfast; began feeling nauseous; vomited and developed a non raised rash on central face and around eyes.
This registered nurse was splashed in the eye with varicella virus vaccine live. Subsequently, the pt experienced a stinging sensation in the eye. She washed the eye out with water for 5-10 minutes. Her vision was normal, but the eye felt stingy. Follow up data states patient recovered 03/15/2000.
Information has been received from a nurse concerning a 12 year old female who on 09-JUN-1997 was vaccination with the first dose of VARIVAX (Oka/Merck) (lot # not reported).  There was no concomitant medication.  No medical history or drug allergy was reported.  After receiving the second dose of VARIVAX (Oka/Merck) (lot # 662458/1330X), 0.5ml, subcutaneously on 01-DEC-2008, the patient experienced swelling and redness on her arm at the injection site.  The patient sought medical attention by phone call.  At the time of the report, the patient was recovering.  This is one of several reports from the same source.   Additional information has been requested.
Rash at the site of shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at the site of shot) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041120A and 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Diabetes.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at the site of shot). On 27-Feb-2021, VACCINATION SITE RASH (Rash at the site of shot) had resolved.            No concomitant medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: On 03-May-2021: Reporter details updated, dose details updated, event details updated and medical history added.